Role of Clinical Pharmacist in the Management of Myocardial Infaraction: A Prospective Observational Study

  • Behara Prathyusha Department of Pharmacy Practice, Viswanadha Institute of Pharmaceutical Sciences, Mindivanipalem, Visakhapatnam, 531173
    prathyusnowy415@gmail.com
  • Rushi Tarra Department of Pharmacy Practice, Viswanadha Institute of Pharmaceutical Sciences, Mindivanipalem, Visakhapatnam, 531173
  • Yerni Kumari Tippana Department of Pharmacy Practice, Viswanadha Institute of Pharmaceutical Sciences, Mindivanipalem, Visakhapatnam, 531173

Abstract

The aim of the present study was to analyze myocardial infarction- Age related risk factors, complications and management.Valuation of age related risk factors in MI patients, identification of frequent type of myocardial infarction, Evaluating the effectiveness of thrombolytic therapy and primary intervention in patients with MI, Assessment of complications of MI and Studying the impact of concomitant diseases on different types of complications. A Prospective observational case series study with 130 cases of patients with myocardial infarction and this study were conducted in department of cardiology in maharaja institute of medical sciences and our work conducted for a period 6 months and we have strictly adhere the Inclusion and exclusion criteria. We concluded that males were more prone to develop MI than females. Incidence of MI was high in age group 51-60 yrs. Cigarette smoking was identified as a major risk factor indicating that life style plays a dominant role than concomitant disorders for early incidence of MI in present generations. Younger population were predisposed to unhealthy life style like smoking, alcohol, fatty diet and we also find out that TLT was effective in treatment of MI. Also, TLT reduced the need for PTCA, and the reason behind subjects required PTCA even after receiving TLT was advanced age. Older subjects were primarily treated with PTCA.

Keywords: Myocardial Infarction, 130 Cases, Concomitant Diseases, LifeStyle Management, Six Months

Downloads

Download data is not yet available.

References

1. Thygesen K, Alpert JS, Jaffe AS, et al. Third universal definition of myocardial infarction. J Am Coll Cardiol.2012 Oct 16. 60 (16):1581-98.
2. Lippi G, Sanchis-Gomar F, Cervellin G. Chest pain, dyspnea and other symptoms in patients with type 1 and 2 myocardial infarction. A literature review. Int J Cardiol 2016;215:20-2. 10.1016/j.ijcard.2016.04.045.
3. GBD 2015 Disease and Injury Incidence and Prevalence, Collaborators. (8 October 2016). "Global, regional, and national incidence, prevalence, and years lived with disability for 310 diseases and injuries, 1990–2015: a systematic analysis for the Global Burden of Disease Study 2015.". Lancet. 388 (10053): 1545–1602. PMC5055577 PMID 27733282. doi:10.1016/S0140-6736(16)31678-6
4. Lim SS, Vos T, Flaxman AD, Danaei G, Shibuya K, Adair-Rohani H, et al. A comparative risk assessment of burden of disease and injury attributable to 67 risk factors and risk factor clusters in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet 2012;380:2224-60.
5. Rosamond WD, Chambless LE, Folsom AR, et al. Trends in the incidence of myocardial infarction and in mortality due to coronary heart disease. New England Journal of Medicine. 1998;339:861–867.
6. McGovern PG, Pankow JS, Shahar E, et al. Recent trends in acute coronary heart disease--mortality, morbidity, medical care, and risk factors. The Minnesota Heart Survey Investigators. New England Journal of Medicine. 1996;334(14):884–890.
7. McGovern PG, Jacobs DR, Jr, Shahar E, et al. Trends in acute coronary heart disease mortality, morbidity, and medical care from 1985 through 1997: the Minnesota heart survey. Circulation. 2001;104(1):19–24.
8. Goldberg RJ, Yarzebski J, Lessard D, Gore JM. A two-decades (1975 to 1995) long experience in the incidence, in-hospital and long-term case-fatality rates of acute myocardial infarction: a community-wide perspective. J Am Coll Cardiol. 1999;33(6):1533–1539.
9. Roger VL, Jacobsen SJ, Weston SA, et al. Trends in the incidence and survival of patients with hospitalized myocardial infarction, Olmsted County, Minnesota, 1979 to 1994. Ann Intern Med. 2002 Mar 5;136(5):341–348.
10. Lindsted KD, Fraser Ge, Steinkohl M, Beeson WL. Healthy volunteer effect in a cohort study: Temporal resolution in the adventist health study. Journal of Clinical Epidemiology. 1996;49(7):783–790. [.]
11. Hellermann JP, Goraya TY, Jacobsen SJ, et al. Incidence of heart failure after myocardial infarction: Is it changing over time? Am J Epidemiol. 2003; 157:1101–1107.
12. Hellermann JP, Reeder GS, Jacobsen SJ, Weston S, Killian J, Roger VL. Longitudinal Trends in the Severity of Acute Myocardial Infarction: A Population Study in Olmsted County, MN. American Journal of Epidemiology. 2002;156:246–253.
13. Goff DC, Jr, Howard G, Wang CH, et al. Trends in severity of hospitalized myocardial infarction: the atherosclerosis risk in communities (ARIC) study, 1987–1994. Am Heart J. 2000;139(5):874–880.
14. Hellermann JP, Reeder GS, Jacobsen SJ, Weston S, Killian J, Roger VL. Has The Severity of Acute Myocardial Infarction Changed Over Time? A Population-Based Study in Olmsted County, MN. Circulation. 2001;104:II-787.
15. Meier MA, Al-Badr WH, Cooper JV, et al. The new definition of myocardial infarction: diagnostic and prognostic implications in patients with acute coronary syndromes. Arch Intern Med. 2002 Jul 22;162(14):1585–1589.
16. Koukkunen H, Penttila K, Kemppainen A, et al. Differences in the diagnosis of myocardial infarction by troponin T compared with clinical and epidemiologic criteria. Am J Cardiol. 2001;88(7):727–731.
17. Kontos MC, Fritz LM, Anderson FP, Tatum JL, Ornato JP, Jesse RL. Impact of the troponin standard on the prevalence of acute myocardial infarction. Am Heart J Sep. 2003;146(3):446–452.
18. Jaffe AS. Elevations of troponin - False positive, the real truth. Cardiovascular Toxicology. 2001;1(2):87–92.
19. Jaffe AS, Katus H. Acute coronary syndrome biomarkers: the need for more adequate reporting. Circulation. 2004;110(2):104–106. [.]
20. Jaffe A. Caveat emptor. Am J Med. 2003 Aug 15;115(3):241–244.
Statistics
87 Views | 46 Downloads
How to Cite
Behara, P., R. Tarra, and Y. K. Tippana. “Role of Clinical Pharmacist in the Management of Myocardial Infaraction: A Prospective Observational Study”. World Journal of Current Medical and Pharmaceutical Research, Vol. 2, no. 2, Apr. 2020, pp. 100-7, doi:10.37022/WJCMPR.2020.2204.
Section
Research Articles